A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D ...

The new strategy shares themes with health secretary Robert F. Kennedy Jr.’s Make America Health Again agenda. He has called ...

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

In this edition of STAT's Health Tech newsletter: the latest on GLP-1 microdosing, AI for medical coding and more.

A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year.

Fewer pre-teens and adolescents are vaping nicotine these days than in previous years. But a study published yesterday in ...

We’re also continuing to track the fallout from all the recent FDA controversies.

Sobriety didn’t restore the old version of me; it allowed me to build a new one from the driftwood of the past,” ...

In the late 1960s, scientists discovered a miracle drug for Parkinson’s disease — a simple, inexpensive dopamine-replacement ...

Sarepta Therapeutics delivered a disastrous third-quarter earnings performance. A long-delayed confirmatory clinical trial of ...